Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts)

Size: px
Start display at page:

Download "Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts)"

Transcription

1 Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts) Roselyne TOBY,MD, ID specialist Infectious Disease Unit/Yaounde Central Hospital ANRS Site Cameroon DLMEP-MoH

2 Outline Background and introductory remarks Second 90 challenges Some solutions 2

3 By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy 3

4 4

5 Why Early ART initiation? TEMPRANO 2056 patients, Ivory Coast 44% lower risk of death or severe HIV-related illness in CD group START 4685 patients, 215 sites, 35 countries Risk of death was 57% lower among those treated early EARLY ART Impact on morbidity, mortality as major outcomes (severe HIV morbidity, HIV disease progression) HIV transmission without significant increase in SAEs. viral suppression rates exceeding 95% (START)and 5

6 WHO ARV Guidelines Evolution : 2002 to 2015 Topic When to start 1 st Line ART 8 options - AZT preferred 2 nd Line ART 3 rd Line ART Viral Load Testing CD4 200 CD4 200 CD Consider CD4 350 for TB Boosted and non-boosted PIs 4 options - AZT preferred Boosted PIs -IDV/r LPV/r, SQV/r 8 options - AZT or TDF preferred - d4t dose reduction Boosted PI - ATV/r, DRV/r, FPV/r LPV/r, SQV/r CD Regardless CD4 for TB and HBV 6 options & FDCs - AZT or TDF preferred - d4t phase out Boosted PI - Heat stable FDC: ATV/r, LPV/r CD Regardless CD4 for TB, HBV PW and SDC - CD4 350 as priority 1 preferred option & FDCs - TDF and EFV preferred across all pops Boosted PIs - Heat stable FDC: ATV/r, LPV/r Towards treatment initiation at any CD4 cell count Continue with FDC approach and phased introduction of new options (DTG, EFV 400 ) Add more heat stable PI options (DRV/r) and new strategies (NRTI sparing regimens) None None None DRV/r, RAL, ETV DRV/r, RAL, ETV Encourage HIV DR to guide No No (Desirable) Earlier initiation Simpler treatment Less toxic, more robust regimens Yes (Tertiary centers) Yes (Phase in approach) Better and simpler monitoring Yes (preferred for monitoring, use of PoC, DBS) Support for scale up of VL using all technologies 6 Courtesy of Eholie S. WHO, 2015

7 Clin Infect Dis. (2011) 52 (6):

8 Recommandations OMS

9 Second 90 challenges 9

10 ART coverage and GAPS (!) UNAIDS, Report on the global AIDS epidemic,

11 Challenges: Health care services Maintaining quality care + ART adherence Retention in care Continuous drug supplies Lifelong, high-quality HIV treatment will require well-functioning, accessible, and affordable health care services. 11

12 Challenges: Health care services Retention rates for ART at 12, 24 and 60 months for selected countries Retention in HIV Program Meeting Report, Geneva,

13 Challenges: Health care services Centralization of HIV treatment services in many settings reduces the success of treatment program Tanser F et al. Science,

14 Challenges: Lack of human ressources Health personnel/ Inhabitants Africa World Doctors Nurses Pharmacist/auxiliaries Dentists Source: World Health Statistics

15 Challenges: societal aspects Stigma and discrimination (eg: in one HIV-infected children lost to follow-up in Malawi) Punitive laws criminalizing HIV exposure transmission or non-disclosure Punitive laws targeting key populations 15

16 Challenges : patients treatment acceptance 2562 HIV-infected, 743 eligible for ART (CD4 <200 cells/µl, 2009 SA guidelines) 148 refused to initiate ART Katz IT, AIDS

17 Challenges : Money, money, money Need in increase of: In-country contributions Global funding :Global Fund and PEPFAR Source : UNAIDS, Report on the global AIDS epidemic,

18 Persistent dependency on international Dependency of countries national HIV response on international sources financing Source : UNAIDS, Report on the global AIDS epidemic,

19 Some solutions 19

20 Tailored delivery strategies Flexible evening and weekend clinic hours for adult men, workplace programs Partnerships with the private sector and service systems Tailored approaches critical for key populations: people living in remote areas, migrants, prisoners... Decentralization Task shifting+++ 20

21 Tailored delivery strategies Family-centred service delivery model marked increase in paediatric HIV treatment uptake (Uganda) 21

22 Simple, standardized and well tolerated regimen 22

23 Community based interventions: MSF experiences Adherence clubs (over 231 clubs and approximately 6000 patients) Community points of distribution of ART drugs (DRC) Community groups of antiretroviral therapy (Mozambique) Spacing appointments and Fast Track renewal antiretroviral treatment (Malawi) Use of trained non professional to allow community adherence+++ Source: Administration communautaire de la the rapie antire trovirale, MSF-ONUSIDA,

24 No drug stocks-out!!! Ceilings for ART drugs for facilities* Simplified drug procurement chain at national level Multiple donors for ordering and procurement* Countries Advocacy to mobilize funds * Anthony D Harries and al: Bull World Health Organ Feb; 85(2): Erick J schouten and al: J Int AIDS Soc. 2011; 14(Suppl 1): S4. Published online 2011 Jul 6 24

25 Thank you! 25

Medical Challenges of HIV/AIDS pandemic: The WHO perspective. SOLTHIS HIV Forum

Medical Challenges of HIV/AIDS pandemic: The WHO perspective. SOLTHIS HIV Forum Medical Challenges of HIV/AIDS pandemic: The WHO perspective SOLTHIS HIV Forum Marco Vitoria HIV/AIDS Department World Health Organization September 2013 Topic 2002 2003 2006 2010 2013 When to start 1

More information

Overview of 2013 WHO consolidated ARV guidelines and update plans. Marco Vitoria HIV/AIDS Department WHO Geneva September 2014

Overview of 2013 WHO consolidated ARV guidelines and update plans. Marco Vitoria HIV/AIDS Department WHO Geneva September 2014 AMDS ANNUAL STAKEHOLDERS AND PARTNERS MEETING Overview of 2013 WHO consolidated ARV guidelines and update plans Marco Vitoria HIV/AIDS Department WHO Geneva September 2014 AMDS ANNUAL STAKEHOLDERS AND

More information

Progress toward Universal ART Access: Innovations and Treatment 2.0. Marco Vitoria World Health Organization September 2013

Progress toward Universal ART Access: Innovations and Treatment 2.0. Marco Vitoria World Health Organization September 2013 Progress toward Universal ART Access: Innovations and Treatment 2.0 Marco Vitoria World Health Organization September 2013 The need for scalable, more efficient treatment models Simpler drugs Point of

More information

PRIORITIES FOR HIV/AIDS PROCUREMENT AND PRODUCT DEVELOPMENT

PRIORITIES FOR HIV/AIDS PROCUREMENT AND PRODUCT DEVELOPMENT PRIORITIES FOR HIV/AIDS PROCUREMENT AND PRODUCT DEVELOPMENT Dr Chewe Luo MMed (Paeds), Mtrop Paed, PhD Senior Adviser and Team Leader Country Programme Scale up HIV Section Programme Division UNICEF, NY

More information

CADO/PADO: Update on 2015 WHO Consolidated guidelines Towards Treat All in the context of SDGs

CADO/PADO: Update on 2015 WHO Consolidated guidelines Towards Treat All in the context of SDGs CADO/PADO: Update on 2015 WHO Consolidated guidelines Towards Treat All in the context of SDGs Meg Doherty, Treatment and Care Coordinator WHO HQ Outline What s new in ARV Guidelines Drug optimisation

More information

Is current first line ART good enough? Francois Venter Wits Reproductive Health & HIV Research Institute

Is current first line ART good enough? Francois Venter Wits Reproductive Health & HIV Research Institute Is current first line ART good enough? Francois Venter Wits Reproductive Health & HIV Research Institute Results: by April 2011 Budget: $3.5 billion 80% of 3,686 health facilities providing ARVs 50% ARV

More information

Review of recent changes in WHO and national paediatric care guidelines Dr. Chewe Luo UNICEF New York City, USA

Review of recent changes in WHO and national paediatric care guidelines Dr. Chewe Luo UNICEF New York City, USA Review of recent changes in WHO and national paediatric care guidelines Dr. Chewe Luo UNICEF New York City, USA Review of recent changes in WHO and national paediatric care guidelines Dr. Chewe Luo MMed

More information

New Directions in the 2015 Consolidated ARV Guidelines Update. Meg Doherty, MD, PhD, MPH 19 July 2015 WHO Satellite Vancouver IAS 2015

New Directions in the 2015 Consolidated ARV Guidelines Update. Meg Doherty, MD, PhD, MPH 19 July 2015 WHO Satellite Vancouver IAS 2015 New Directions in the 2015 Consolidated ARV Guidelines Update Meg Doherty, MD, PhD, MPH 19 July 2015 WHO Satellite Vancouver IAS 2015 Objectives of Presentation 2015 ARV Guidelines update - why now? Overview

More information

Treat All : From Policy to Action - What will it take?

Treat All : From Policy to Action - What will it take? Strategy Finance Integration Cascade of services People centred Political Will Treat All : From Policy to Action - What will it take? Thursday, 9 June, 13.00 14.30 Conference Room 11, United Nations Questions

More information

Scaling Up Treatment in Zimbabwe: The path to high coverage

Scaling Up Treatment in Zimbabwe: The path to high coverage Scaling Up Treatment in Zimbabwe: The path to high coverage IAS Conference Dr. Tsitsi Mutasa-Apollo ART Programme Coordinator, Zimbabwe 30 th June, 2013 Kuala Lumpur, Malaysia Outline Introduction Background

More information

A smart and doable investment

A smart and doable investment 90-90-90 A smart and doable investment As of December 2013 Adults and children living with HIV Adults and children newly infected Adult & child deaths due to AIDS 35.0 million [33.2 million 37.2 million]

More information

Update on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines

Update on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines WHO 2013 Consolidated ARV Guidelines Update on global guidelines H I V / A I D S DEPARTMENT and emerging issues on perinatal HIV prevention Children & HIV, St. Petersburg, Russia Sept 25-26, 2014 Dr. Nathan

More information

Financing ART in low- and middleincome. Karl L. Dehne UNAIDS

Financing ART in low- and middleincome. Karl L. Dehne UNAIDS Financing ART in low- and middleincome countries Karl L. Dehne UNAIDS Close the global resource gap by 2015 $6 billion annually, overall target (between $22 billion and $24 billion) Programmes must become

More information

Achieving the 3 rd 90 in PEPFAR-supported countries:

Achieving the 3 rd 90 in PEPFAR-supported countries: Center for Global Health Achieving the 3 rd 90 in PEPFAR-supported countries: What will it take? Is it enough? Elliot Raizes, MD Division of Global HIV and TB Centers for Disease Control and Prevention

More information

Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access -

Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access - Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access - Associate Professor, Bui Duc Duong, MD, Ph.D. Deputy Director General, Ministry of Health Socialist Republic of Viet Nam HIV

More information

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS Investing for Impact Prioritizing HIV Programs for GF Concept Notes Lisa Nelson, WHO Iris Semini, UNAIDS Top 5 Lessons Learned 1 2 3 4 5 Prioritize within the allocation amount Separate above allocation

More information

HIV und AIDS- was gibt es Neues für die Arbeit vor Ort?

HIV und AIDS- was gibt es Neues für die Arbeit vor Ort? HIV und AIDS- was gibt es Neues für die Arbeit vor Ort? Dr. med. Ralf Weigel Liverpool School of Tropical Medicine ralf.weigel@lstmed.ac.uk foring UPDATE 2017 Humanitäre Hilfe und Entwicklungszusammenarbeit

More information

Unmet needs and challenges of current ART in South Africa. Michelle Moorhouse 21 Nov 2015

Unmet needs and challenges of current ART in South Africa. Michelle Moorhouse 21 Nov 2015 Unmet needs and challenges of current ART in South Africa Michelle Moorhouse 21 Nov 2015 SA Snapshot Òct 2015 6-7 million HIV-positive: 18% world total, 25% of Southern Africa 3.2 on first line ART: consume

More information

What's new in the WHO ART guidelines How did markets react?

What's new in the WHO ART guidelines How did markets react? WHO 2013 ARV Guidelines What's new in the WHO ART guidelines How did markets react? Dr. J. Perriëns Coordinator, HIV Technology and Commodities HIV department, WHO, Geneva When to start in adults Starting

More information

Updates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013

Updates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013 Updates on Revised Antiretroviral Treatment Guidelines 2013 Overview 27 March 2013 Introduction of Fixed Dose combination (FDC) FDCs will be available in facilities on 1 April 2013 The FDC ARV that will

More information

ART Optimization (New emerging molecules) KPA PRE-CONFERENCE 24 th April 2018 Dr Justine Jelagat Odionyi (EGPAF)/Dr Virginia Karanja(CHS)

ART Optimization (New emerging molecules) KPA PRE-CONFERENCE 24 th April 2018 Dr Justine Jelagat Odionyi (EGPAF)/Dr Virginia Karanja(CHS) ART Optimization (New emerging molecules) KPA PRE-CONFERENCE 24 th April 2018 Dr Justine Jelagat Odionyi (EGPAF)/Dr Virginia Karanja(CHS) Outline Introduction New ART molecules already adopted Dolutegravir

More information

Differentiated Care Improving Engagement and Retention in HIV Care. Meg Doherty, MD PhD MPH World Health Organization

Differentiated Care Improving Engagement and Retention in HIV Care. Meg Doherty, MD PhD MPH World Health Organization Differentiated Care Improving Engagement and Retention in HIV Care Meg Doherty, MD PhD MPH World Health Organization Why differentiated care and how can it facilitate epidemic control Effects on linkage,

More information

ARV Consolidated Guidelines 2015

ARV Consolidated Guidelines 2015 ARV Consolidated Guidelines 2015 This document outlines the draft list of PICO questions to support systematic review process for the 2015 ARV guidelines process. PICO questions are grouped by clinical

More information

Evolving Realities of HIV Treatment in Resource-limited Settings

Evolving Realities of HIV Treatment in Resource-limited Settings Evolving Realities of HIV Treatment in Resource-limited Settings Papa Salif Sow MD, MSc Department of Infectious Diseases University of Dakar, Senegal Introduction: ARV access in RLS Scale-up of ART has

More information

Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive

Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive DR. Nicholas Muraguri OGW, MD,MPH, MBA, PhD (c) Director, Global Plan Secretariat www.zero-hiv.org

More information

2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents. When to Start and What ART to Use in 1 st and 2 nd Line December 2009

2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents. When to Start and What ART to Use in 1 st and 2 nd Line December 2009 2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents When to Start and What ART to Use in 1 st and 2 nd Line December 2009 Historic Evolution of CD4 Criteria for ART Initiation in

More information

Care of HIV Infected People

Care of HIV Infected People Care of HIV Infected People Patrick Ndase, MD, MPH MTN Annual Meeting Marriott Key Bridge, Arlington, VA April 21-23, 2008 Why Care for HIV infected in such a meeting? Site Core Community Why Care for

More information

Scaling up priority HIV/AIDS interventions in the health sector

Scaling up priority HIV/AIDS interventions in the health sector TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June

More information

Treatment Optimisation Community Condultation Feedback. KENLY SIKWESE AFRICAN COMMUNITY ADVISORY BOARD (AFROCAB) 3 rd May 2016

Treatment Optimisation Community Condultation Feedback. KENLY SIKWESE AFRICAN COMMUNITY ADVISORY BOARD (AFROCAB) 3 rd May 2016 Treatment Optimisation Community Condultation Feedback KENLY SIKWESE AFRICAN COMMUNITY ADVISORY BOARD (AFROCAB) 3 rd May 2016 INTRODUCTION A brief history of ART 1987-90s AZT vecomes available ddi/ddc

More information

Tunisian recommendations on ART : process and results

Tunisian recommendations on ART : process and results Second Arab Congress of Clinical Microbiology and Infectious Diseases May 24-26, 2012. Tunisian recommendations on ART : process and results M. BEN MAMOU UNAIDS Email: BenmamouM@unaids.org M. CHAKROUN

More information

TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES

TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES POLICY BRIEF HIV TREATMENT TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES JULY 2017 WHO This policy brief provides advice on a phased approach to transitioning to new WHO-recommended HIV treatment

More information

Advancing Treatment 2.0: Progress on the 2013 Consolidated Guidelines What s new

Advancing Treatment 2.0: Progress on the 2013 Consolidated Guidelines What s new Advancing Treatment 2.0: Progress on the 2013 Consolidated Guidelines What s new H I V / A I D S D e p a r t m e n t WHO HQ Meg Doherty, MD, MPH, PhD Coordinator Treatment and Care November 5, 2012 1 Overview

More information

Understanding the unmet medical needs with current ART

Understanding the unmet medical needs with current ART Thanks: Polly Clayden, Francesca Conradie, Loyd Mulenga, Gary Maartens, Andrew Hill, David Ripin, Elli Katabira, Chris Duncombe, Nathan Ford, Marco Vitoria, WHO, Trip Gullik Industry: Gilead, Janssen,

More information

BUDGET AND RESOURCE ALLOCATION MATRIX

BUDGET AND RESOURCE ALLOCATION MATRIX Strategic Direction/Function ILO Strengthened capacity of young people, youth-led organizations, key service providers and partners to develop, implement, monitor and evaluate HIV prevention programmes

More information

Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)

Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW) Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW) Submission: Elizabeth Glaser Pediatric AIDS Foundation June 2013 Introduction:

More information

The CQUIN Learning Network

The CQUIN Learning Network The CQUIN Learning Network Adolescents Living with HIV: National Guidelines, Minimum Package, Challenges and Priorities Swaziland Ms Nobuhle Mthethwa MOH- SWAZILAND October 24-27, 2017 Johannesburg, South

More information

Existing and most needed paediatric ARV formulations

Existing and most needed paediatric ARV formulations Existing and most needed paediatric ARV formulations Martina Penazzato Paediatric HIV advisor WHO HIV Department, Geneva Mach 7th 2016 Paediatric coverage still lags behind 45 40 35 30 25 20 15 10 5 0

More information

targets for HIV-positive children

targets for HIV-positive children Accessing antiretroviral therapy (ART) is a matter of life and death for HIV-infected children. Without ART, half of children born with HIV die by the age of two years, and 80 percent die by the age of

More information

HIV Treatment Update. Awewura Kwara, MD, MPH&TM Associate Professor of Medicine and Infectious Diseases Brown University

HIV Treatment Update. Awewura Kwara, MD, MPH&TM Associate Professor of Medicine and Infectious Diseases Brown University HIV Treatment Update Awewura Kwara, MD, MPH&TM Associate Professor of Medicine and Infectious Diseases Brown University Outline Rationale for highly active antiretroviral therapy (HAART) When to start

More information

The use of antiretroviral agents during pregnancy in Canada and compliance with North-American guidelines

The use of antiretroviral agents during pregnancy in Canada and compliance with North-American guidelines The use of antiretroviral agents during pregnancy in Canada and compliance with North-American guidelines I. Boucoiran, T. Lee, K. Tulloch, L. Sauve, L. Samson, J. Brophy, M. Boucher and D. Money For and

More information

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants hiv/aids Programme Programmatic update Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants EXECUTIVE SUMMARY April 2012 EXECUTIVE SUMMARY Recent developments

More information

Current challenges of paediatric HIV care Experiences in Sub-Saharan Africa. Dr. Elizabeth Obimbo University of Nairobi Nairobi, Kenya

Current challenges of paediatric HIV care Experiences in Sub-Saharan Africa. Dr. Elizabeth Obimbo University of Nairobi Nairobi, Kenya Current challenges of paediatric HIV care Experiences in Sub-Saharan Africa Dr. Elizabeth Obimbo University of Nairobi Nairobi, Kenya Current Challenges of Paediatric HIV Care What is Happening in the

More information

Update on CADO/PADO: what are the challenges in using the current guidelines and foreseen ARV revisions: opportunities and challenges

Update on CADO/PADO: what are the challenges in using the current guidelines and foreseen ARV revisions: opportunities and challenges Update on CADO/PADO: what are the challenges in using the current guidelines and foreseen ARV revisions: opportunities and challenges Treatment and Care Team Meg Doherty, Marco Vitoria, Martina Penazzato,

More information

SHOULD A TRIAL EVALUATING THE USE OF LOW DOSE STAVUDINE BE CONDUCTED?

SHOULD A TRIAL EVALUATING THE USE OF LOW DOSE STAVUDINE BE CONDUCTED? SHOULD A TRIAL EVALUATING THE USE OF LOW DOSE STAVUDINE BE CONDUCTED? ETHICAL, CLINICAL AND COMMUNITY CONSIDERATIONS Eric Goemaere, MD, DTMH, PHD Senior HIV/TB program adviser MSF South Africa We loved

More information

What next? Francois Venter. ART new drugs, new studies. Wits Reproductive Health & HIV Institute

What next? Francois Venter. ART new drugs, new studies. Wits Reproductive Health & HIV Institute Thanks: Polly Clayden, Francesca Conradie, Loyd Mulenga, Gary Maartens, Andrew Hill, David Ripin, Elli Katabira, Chris Duncombe, Nathan Ford, Marco Vitoria, WHO Industry: Gilead, Janssen, ViivV Abbott,

More information

SA HIV Clinicians Society Adult ART guidelines

SA HIV Clinicians Society Adult ART guidelines SA HIV Clinicians Society Adult ART guidelines In draft format Graeme Meintjes (on behalf of the guidelines committee) Selected topics When to start ART First-line Second-line Third-line Patients with

More information

FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030

FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Evidence informed, responsive and sustainable care FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Alti Zwandor UNAIDS Country Director Maseru, Lesotho 9 December

More information

Response to HIV LOGISTICAL AND OTHER PERSPECTIVES

Response to HIV LOGISTICAL AND OTHER PERSPECTIVES Response to HIV LOGISTICAL AND OTHER PERSPECTIVES Margaret Brandeau Department of Management Science and Engineering Department of Medicine Stanford University Topics HIV: A humanitarian crisis Planning

More information

World Health Organization. A Sustainable Health Sector

World Health Organization. A Sustainable Health Sector World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL

More information

2009 Revisions of WHO ART Guidelines. November 2009

2009 Revisions of WHO ART Guidelines. November 2009 2009 Revisions of WHO ART Guidelines November 2009 Guidelines Development Process 01/09 2009 WHO ART guideline revision process Scope of the work 03/09 WHO Guideline review committee approval 04/09 05/09

More information

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each

More information

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 The South African Antiretroviral Treatment Guidelines 2010 Goals of the programme Achieve best health outcomes in the most cost-efficient manner

More information

IATT Optimal List of Paediatric ARV Formulations: Background and Update

IATT Optimal List of Paediatric ARV Formulations: Background and Update IATT Optimal List of Paediatric ARV Formulations: Background and Update Nandita Sugandhi Clinton Health Access Initiative, USA PADO/IATT Update for ARV Manufacturers October 19, 2015 Overview Rationale

More information

The Financial Implications of Reaching Global Treatment and Prevention Goals CHAI slide warehouse

The Financial Implications of Reaching Global Treatment and Prevention Goals CHAI slide warehouse The Financial Implications of Reaching Global Treatment and Prevention Goals CHAI slide warehouse Clinton Health Access Initiative (CHAI) October 2, 2015 As we near global consensus toward test and offer

More information

NAMIBIA INVESTMENT CASE

NAMIBIA INVESTMENT CASE NAMIBIA INVESTMENT CASE OUTLINE Why an Investment Case for HIV Response in Namibia? Investment Scenarios Can we achieve Fast Track and End AIDS as public health threat by 2030? Can we afford it? Efficiencies:

More information

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030 S T A T E M E N T 2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030 World leaders commit to reach three goals and 20 new Fast-Track Targets

More information

INTERNAL QUESTIONS AND ANSWERS DRAFT

INTERNAL QUESTIONS AND ANSWERS DRAFT WHO CONSOLIDATED GUIDELINES ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION Background: INTERNAL QUESTIONS AND ANSWERS DRAFT At the end of 2012, 9.7 million people were receiving

More information

Patient Forecasts for Pipeline ARVs: Adults

Patient Forecasts for Pipeline ARVs: Adults Patient Forecasts for Pipeline ARVs: Adults Presented at: WHO/UNAIDS Annual Meeting with ARV Manufacturers and Stakeholders March 19-20, 2015 Vineet Prabhu Market Intelligence Team, CHAI HIV Access Program

More information

DEPARTMENT. Treatment Recommendations for. Pregnant and Breastfeeding Women: Critical Issues Consolidated ARV Guidelines. Dr.

DEPARTMENT. Treatment Recommendations for. Pregnant and Breastfeeding Women: Critical Issues Consolidated ARV Guidelines. Dr. 2013 Consolidated ARV Guidelines H I V / A I D S Treatment Recommendations for DEPARTMENT Pregnant and Breastfeeding Women: Critical Issues Dr. Nathan Shaffer Objectives of Presentation obackground ooverview

More information

guidance for Goal of this chapter 10.1 Introduction Decision-making process 201

guidance for Goal of this chapter 10.1 Introduction Decision-making process 201 guidance for programme managers 10 10.1 Introduction 200 10.2 Decision-making process 201 10.3 Data to support decision-making 201 10.3.1 Overview 201 10.3.2 National and local HIV epidemiology 202 10.3.3

More information

Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive:

Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Rationale for the call to action, progress to date and dealing with realities Rene Ekpini, MD, MPH Senior Adviser,

More information

HIV Treatment for Adults and Adolescents. Stefano Vella MD Istituto Superiore di Sanità - Rome - Italy

HIV Treatment for Adults and Adolescents. Stefano Vella MD Istituto Superiore di Sanità - Rome - Italy HIV Treatment for Adults and Adolescents Stefano Vella MD Istituto Superiore di Sanità - Rome - Italy www.ias2013.org Kuala Lumpur, Malaysia, 30 June - 3 July 2013 PLHIV in need of ART WHO 2013 Guidelines

More information

Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018

Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018 Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018 Outline Scaling up for Impact Critical Point of the Response Choices of strategies Accelerating Implementation

More information

No. individuals current on treatment (ART) - PEPFAR Indicator Reference Sheets

No. individuals current on treatment (ART) - PEPFAR Indicator Reference Sheets No. individuals current on treatment (ART) - PEPFAR Indicator Reference Sheets 2004-2009 Indicator Reference Sheet Number of individuals receiving antiretroviral therapy at the end of the reporting period,

More information

Overview of Paediatric HIV Treatment and Prevention: From Then to Now. Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda

Overview of Paediatric HIV Treatment and Prevention: From Then to Now. Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda Overview of Paediatric HIV Treatment and Prevention: From Then to Now Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda Outline The plight of HIV infected children (1980s and 1990s) Trends

More information

ON THE FAST-TRACK TO ACCELERATE THE FIGHT AGAINST HIV AND TO END THE AIDS EPIDEMIC BY 2030

ON THE FAST-TRACK TO ACCELERATE THE FIGHT AGAINST HIV AND TO END THE AIDS EPIDEMIC BY 2030 ON THE FAST-TRACK TO ACCELERATE THE FIGHT AGAINST HIV AND TO END THE AIDS EPIDEMIC BY 2030 2016 Political Declaration César A. Núñez 04 June 2017 Fast-Track commitments to end AIDS by 2030 On the Fast-Track:

More information

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges George Siberry, MD, MPH OGAC Senior Technical Advisor for Pediatrics March, 2016 Compared to Adults, Children (

More information

ARV Market Report. The State of the Antiretroviral Drug Market in Low- and Middle-Income Countries. ISSUE 4, November 2013

ARV Market Report. The State of the Antiretroviral Drug Market in Low- and Middle-Income Countries. ISSUE 4, November 2013 ARV Market Report The State of the Antiretroviral Drug Market in Low- and Middle-Income Countries ISSUE 4, November 213 ARV Market Report Clinton Health Access Initiative 1 Table of Contents TABLE OF EXHIBITS...

More information

Differentiated Service Delivery: Taking Innovative Delivery Models to Scale

Differentiated Service Delivery: Taking Innovative Delivery Models to Scale Differentiated Service Delivery: Taking Innovative Delivery Models to Scale Wafaa El-Sadr, MD, MPH, MPA ICAP at Columbia University Outline The Promise of Differentiated Service Delivery (DSD) Scale-up

More information

HIV Drug Resistance (HIVDR)

HIV Drug Resistance (HIVDR) Technical Guidance Note for Round 10 Global Fund HIV Proposals HIV Drug Resistance (HIVDR) Rationale for including HIVDR prevention and assessment in the proposal June 2010 As access to ART services expands,

More information

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR 2015 2020 Presented by Vincent Habiyambere (WHO), Biyi Adesina (Avenir Health) and Meghan Wareham (CHAI) on behalf

More information

Clinical skills building - HIV drug resistance

Clinical skills building - HIV drug resistance Clinical skills building - HIV drug resistance Richard Lessells Clinical case 44-year old HIV-positive male HIV diagnosis 2010 Pre-treatment CD4+ count not known Initiated first-line ART (TDF/FTC/EFV)

More information

Clinical support for reduced drug regimens. David A Cooper The University of New South Wales Sydney, Australia

Clinical support for reduced drug regimens. David A Cooper The University of New South Wales Sydney, Australia Clinical support for reduced drug regimens David A Cooper The University of New South Wales Sydney, Australia Clinical support for reduced drug regimens First line optimisation Virological failure New

More information

HIV TRENDS UNIVERSAL ACCESS TO HIV TREATMENT IN KENYA

HIV TRENDS UNIVERSAL ACCESS TO HIV TREATMENT IN KENYA HIV TRENDS UNIVERSAL ACCESS TO HIV TREATMENT IN KENYA Dr Irene Mukui National AIDS & STD Control Programme 1 Outline Introduction HIV trends and current Statistics Access to ART Successes Challenges 2

More information

Optimizing 2 nd and 3 rd Line Antiretroviral Therapy in Children and Adolescents

Optimizing 2 nd and 3 rd Line Antiretroviral Therapy in Children and Adolescents Optimizing 2 nd and 3 rd Line Antiretroviral Therapy in Children and Adolescents Victor Musiime, MBChB, MMED, PhD Senior Lecturer, Makerere University Investigator, Joint Clinical Research Centre (JCRC)

More information

Global Perspectives on Treat All for Children and Adolescents with HIV. PATA Global Summit Shaffiq Essajee

Global Perspectives on Treat All for Children and Adolescents with HIV. PATA Global Summit Shaffiq Essajee Global Perspectives on Treat All for Children and Adolescents with HIV PATA Global Summit Shaffiq Essajee New HIV infections are declining among children! 47% decline 56% decline 33% decline Courtesy of

More information

90% 90% 90% 30% 10% 5% 70% 90% 95% WHY HIV SELF-TESTING? PLHIV diagnosed PLHIV undiagnosed

90% 90% 90% 30% 10% 5% 70% 90% 95% WHY HIV SELF-TESTING? PLHIV diagnosed PLHIV undiagnosed WHY HIV SELF-TESTING? In 2014, the United Nations set bold new targets, calling on the global community to ensure that by 2020, 90% of all people living with HIV will know their HIV status, 90% of all

More information

Forecasting pipeline ARVs. Joseph Perriëns Sandeep Juneja Aastha Gupta

Forecasting pipeline ARVs. Joseph Perriëns Sandeep Juneja Aastha Gupta Forecasting pipeline ARVs Joseph Perriëns Sandeep Juneja Aastha Gupta Presently: lack of visibility causes a gap between demand and generic production for new drugs Patent Holder R&D Marketing 3-4 yrs

More information

World Food Programme (WFP)

World Food Programme (WFP) UNAIDS 2016 REPORT World Food Programme (WFP) Unified Budget Results and Accountability Framework (UBRAF) 2016-2021 2 Contents Achievements 2 Introduction 2 Innovative testing strategies 2 Access to treatment

More information

Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project

Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project NOVEMBER 2017 An estimated 37 million people are living with HIV today. A response to the need

More information

Overview of HIV in West and Central Africa

Overview of HIV in West and Central Africa Overview of HIV in West and Central Africa Serge Paul Eholié Affiliations: Département de Dermatologie-Infectiologie, UFR des Sciences Médicales, Université Félix Houphouet-Boigny, Abidjan Service des

More information

New Directions on WHO ARV Guidelines 2018

New Directions on WHO ARV Guidelines 2018 New Directions on WHO ARV Guidelines 2018 Elaine Abrams Co-chair WHO Guidelines Development Group ICAP at Columbia University, New York Martina Penazzato Paediatric lead for the HIV Department World Health

More information

WHO HIV Drug Resistance Strategy

WHO HIV Drug Resistance Strategy WHO HIV Drug Resistance Strategy Boston, 27 February 2011 Background Global ART scale-up has been a remarkable achievement benefiting over 5.2 million individuals in resource limited settings Maintaining

More information

Technical guidance for Round 9 Global Fund HIV proposals

Technical guidance for Round 9 Global Fund HIV proposals Technical guidance for Round 9 Global Fund HIV proposals Broad Area Service Delivery Area TREATMENT Prevention and assessment of HIV drug resistance (HIVDR) This technical brief provides key information

More information

EXPRESSION OF INTEREST New Horizons Advancing Pediatric HIV Care Donation Program

EXPRESSION OF INTEREST New Horizons Advancing Pediatric HIV Care Donation Program EXPRESSION OF INTEREST New Horizons Advancing Pediatric HIV Care Donation Program Background With the release of the 2014 UNAIDS 90-90- 90 treatment target, programs are expected to scale- up efforts to

More information

Rajesh T. Gandhi, M.D.

Rajesh T. Gandhi, M.D. HIV Treatment Guidelines: 2010 Rajesh T. Gandhi, M.D. Case 29 yo M with 8 weeks of cough and fever. Diagnosed with smear-positive pulmonary TB. HIV-1 antibody positive. CD4 count 361. HIV-1 RNA 23,000

More information

Evolving HIV Treatment Paradigms What we need to know

Evolving HIV Treatment Paradigms What we need to know Evolving HIV Treatment Paradigms What we need to know Benjamin Young International Association of Providers of AIDS Care Washington, DC, USA Evolving HIV Treatment Paradigms When/who to treat Better medicines

More information

The global plan to eliminate mother to child transmission (emtct) of HIV: challenges in integration and of therapeutic strategies

The global plan to eliminate mother to child transmission (emtct) of HIV: challenges in integration and of therapeutic strategies Training Course in Sexual and Reproductive Health Research 2014 Module: Principles and Practice of Sexually Transmitted Infections Prevention and Care The global plan to eliminate mother to child transmission

More information

Crafting an ART Regimen for Initiation or Salvage: Are NRTI s Necessary?

Crafting an ART Regimen for Initiation or Salvage: Are NRTI s Necessary? NORTHWEST AIDS EDUCATION AND TRAINING CENTER Crafting an ART Regimen for Initiation or Salvage: Are NRTI s Necessary? Brian R. Wood, MD Assistant Professor of Medicine, University of Washington Medical

More information

ART TREATMENT PROGRAMME 2004

ART TREATMENT PROGRAMME 2004 Presentation title ART TREATMENT PROGRAMME 2004 Cabinet decision in 29 th November 2003 Initial sites were hospital based, required central review National Costing Model of HIV/AIDS Treatment 2010 Cost

More information

Dr Carole Wallis, PhD Medical Director, BARC-SA Head of the Specialty Molecular Division, Lancet Laboratories, South Africa

Dr Carole Wallis, PhD Medical Director, BARC-SA Head of the Specialty Molecular Division, Lancet Laboratories, South Africa Dr Carole Wallis, PhD Medical Director, BARC-SA Head of the Specialty Molecular Division, Lancet Laboratories, South Africa Transmitted drug resistance Resistance patterns in first-line failures in adults

More information

What is Treatment Optimisation (TO)

What is Treatment Optimisation (TO) Outline What is treatmen optimisation Why is treatment optimisation important for the future of HIV treatment and care Drugs optimisation Some strategies for moving the TO agend forward Discussion: Why

More information

ADOLESCENTS AND HIV:

ADOLESCENTS AND HIV: Elizabeth Glaser Pediatric AIDS Foundation Until no child has AIDS. Photo by Eric Bond/EGPAF, 2015 ADOLESCENTS AND HIV: PRIORITIZATION FOR ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION PROGRAMS, ADVOCACY

More information

MANAGING HIV IN CHILDREN: BEST PRACTICES

MANAGING HIV IN CHILDREN: BEST PRACTICES MANAGING HIV IN CHILDREN: BEST PRACTICES Dr. Mo Archary Paediatric Infectious Diseases Specialist University of KwaZulu Natal/ King Edward VIII Hospital Overview Global state of paediatric ART Filling

More information

Paediatric Infectious Diseases Unit, Red Cross War Memorial Children s Hospital & University of Cape Town

Paediatric Infectious Diseases Unit, Red Cross War Memorial Children s Hospital & University of Cape Town A Public Sector Antiretroviral Treatment Programme for Treatment-Experienced Children and Adolescents in the Western Cape Province of South Africa Using Darunavir/Ritonavir-, Raltegravir- and Etravirine-Containing

More information

The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT

The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT Peter McDermott Managing Director, CIFF 19 th Board meeting, Geneva 6 th May 2009 Investment Criteria Measurable...change

More information

Technical Guidance Note for Global Fund HIV Proposals. TREATMENT - Antiretroviral Treatment-infants, children and adults

Technical Guidance Note for Global Fund HIV Proposals. TREATMENT - Antiretroviral Treatment-infants, children and adults Technical Guidance Note for Global Fund HIV Proposals TREATMENT - Antiretroviral Treatment-infants, children and adults May 2010 This technical brief is designed to provide key technical information to

More information

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012 PMTCT Update Update on PMTCT Margarett Davis, MD, MPH Chief, Maternal and Child Health Branch Division of Global HIV/AIDS Centers for Disease Control and Prevention (CDC) African Health Profession Regulatory

More information

WESTERN CAPE ART GUIDELINES PRESENTATION 2013

WESTERN CAPE ART GUIDELINES PRESENTATION 2013 WESTERN CAPE ART GUIDELINES PRESENTATION 2013 The WC guidelines are based on SA National ART guidelines dated 24th March 2013 Acknowledgement goes to members of the Adult and Paediatric HAST policy advisory

More information

UNICEF/Malawi/2015/Schermbrucker. policy brief 2016 UPDATE

UNICEF/Malawi/2015/Schermbrucker. policy brief 2016 UPDATE UNICEF/Malawi/2015/Schermbrucker policy brief IATT PAEDIATRIC ARV FORMULARY AND LIMITED-USE LIST: 2016 UPDATE BACKGROUND Delivery of antiretroviral treatment (ART) to children living with HIV is associated

More information